Your browser doesn't support javascript.
loading
Independent prognostic impact of CD15 on complete remission achievement in patients with acute myeloid leukemia.
Chisini, Marta; Stefanizzi, Caterina; Ceglie, Teresa; Raponi, Sara; Vozella, Federico; Colafigli, Gioia; Salaroli, Adriano; D'Angiò, Mariella; Mancini, Marco; Diverio, Daniela; Breccia, Massimo; Mancini, Francesca; Minotti, Clara; Trisolini, Silvia; Capria, Saveria; Testi, Anna Maria; Guarini, Anna; Latagliata, Roberto; De Propris, Maria Stefania; Foà, Robin.
Afiliação
  • Chisini M; Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome, Italy.
  • Stefanizzi C; Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome, Italy.
  • Ceglie T; Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome, Italy.
  • Raponi S; Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome, Italy.
  • Vozella F; Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome, Italy.
  • Colafigli G; Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome, Italy.
  • Salaroli A; Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome, Italy.
  • D'Angiò M; Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome, Italy.
  • Mancini M; Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome, Italy.
  • Diverio D; Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome, Italy.
  • Breccia M; Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome, Italy.
  • Mancini F; Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome, Italy.
  • Minotti C; Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome, Italy.
  • Trisolini S; Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome, Italy.
  • Capria S; Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome, Italy.
  • Testi AM; Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome, Italy.
  • Guarini A; Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome, Italy.
  • Latagliata R; Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome, Italy.
  • De Propris MS; Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome, Italy.
  • Foà R; Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome, Italy.
Hematol Oncol ; 35(4): 804-809, 2017 Dec.
Article em En | MEDLINE | ID: mdl-27400753
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Antígenos CD15 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Antígenos CD15 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article